Exploratory analysis of the visceral disease (VD) patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC).
Oscar B. Goodman
Consultant or Advisory Role - Veridex
Honoraria - Veridex
Thomas W. Flaig
Consultant or Advisory Role - Sanofi
Honoraria - Amgen
Research Funding - Amgen; Cougar Biotechnology; Medivation; Sanofi ; Veridex
Other Remuneration - Cougar Biotechnology
Arturo Molina
Employment or Leadership Position - Janssen Pharmaceutical
Stock Ownership - Johnson & Johnson
Peter Mulders
Consultant or Advisory Role - Astellas Pharma; AstraZeneca; GlaxoSmithKline; Johnson & Johnson
Honoraria - Janssen Pharmaceutical ; Johnson & Johnson
Research Funding - Bayer
Henrik Suttmann
Consultant or Advisory Role - Astellas Pharma; Ferring; Ipsen; Janssen-Cilag; Janssen-Cilag; Medac; Sanofi
Honoraria - Janssen-Cilag
Research Funding - Astellas Pharma; Janssen-Cilag
Jinhui Li
Employment or Leadership Position - Janssen Pharmaceutical ; Janssen R&D
Stock Ownership - Johnson & Johnson; Johnson & Johnson
Thian San Kheoh
Employment or Leadership Position - Janssen Pharmaceutical
Stock Ownership - Johnson & Johnson
Johann Sebastian De Bono
Employment or Leadership Position - The Institute of Cancer Research ; The Institute of Cancer Research ; The Institute of Cancer Research ; The Institute of Cancer Research
Consultant or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
Honoraria - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
Howard I. Scher
Consultant or Advisory Role - Amgen; Amgen; Amgen; Aragon Pharmaceuticals; Aragon Pharmaceuticals; Aragon Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Centocor Ortho Biotech; Centocor Ortho Biotech; Centocor Ortho Biotech; Cougar Biotechnology; Cougar Biotechnology; Cougar Biotechnology; Exelixis; Exelixis; Exelixis; Foundation Medicine; Foundation Medicine; Foundation Medicine; Janssen; Janssen Global; Janssen Global; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Medivation; Medivation; Medivation; Millennium; Millennium; Millennium; Novartis; Novartis; Novartis; Orion/Endo; Orion/Endo; Orion/Endo; Sanofi ; Sanofi ; Sanofi ; Veridex; Veridex; Veridex
Stock Ownership - Genta; Genta; Genta; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
Honoraria - Amgen; Amgen; Amgen; Centocor Ortho Biotech; Centocor Ortho Biotech; Centocor Ortho Biotech; Millennium; Millennium; Millennium; Novartis; Novartis; Novartis; Orion/Endo; Orion/Endo; Orion/Endo; Sanofi ; Sanofi ; Sanofi
Research Funding - Aragon Pharmaceuticals; Aragon Pharmaceuticals; Aragon Pharmaceuticals; Centocor Ortho Biotech; Centocor Ortho Biotech; Centocor Ortho Biotech; Cougar Biotechnology; Cougar Biotechnology; Cougar Biotechnology; Exelixis; Exelixis; Exelixis; Medivation; Medivation; Medivation; Veridex; Veridex; Veridex
Other Remuneration - Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; Cougar Biotechnology; Cougar Biotechnology; Cougar Biotechnology; Exelixis; Exelixis; Exelixis; Medivation; Medivation; Medivation; Millennium; Millennium; Millennium; Novartis; Novartis; Novartis; Orion/Endo; Orion/Endo; Orion/Endo; Sanofi ; Sanofi ; Sanofi